Circulating tumor DNA accurately predicts disease progression and genotype alterations in postoperative adjuvant EGFR-TKI resistance: a case report

BACKGROUND: Circulating tumor DNA (ctDNA) is receiving more and more attention for its role in tumor screening and disease surveillance in cancer patients. However, it is unclear whether ctDNA can be used to predict recurrence and metastasis in patients after radical resection due to the resulting l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Zhen, Liu, Chengwu, Deng, Senyi, Lin, Feng, Husain, Hatim, Santarpia, Mariacarmela, Liu, Lunxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
iMDT Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554680/
https://www.ncbi.nlm.nih.gov/pubmed/36248329
http://dx.doi.org/10.21037/tlcr-22-562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554680/
https://www.ncbi.nlm.nih.gov/pubmed/36248329
http://dx.doi.org/10.21037/tlcr-22-562

Ejemplares similares